Kagan & Soai Clinch 2026 Chemistry Nobel for Triggering Homochirality in Lab Reactions

Chemists have wrestled with molecular handedness since Louis Pasteur painstakingly separated tartaric acid crystals in 1848, and the stakes became tragically clear when the wrong thalidomide enantiomer caused birth defects in the early 1960s. Kagan and Soai’s work closes that 178-year arc by showing that mere trace asymmetries, amplified through autocatalysis, can tip a reaction toward 100 % single-handed products—echoing the self-reinforcing feedbacks that underlie life’s own homochirality and, by analogy, the 1953 Miller–Urey experiment that hinted at abiogenesis pathways. Their recognition also corrects the omission of Kagan from the 2001 Nobel on asymmetric catalysis, illustrating how scientific credit can lag behind consensus. Over the long term, the ability to dictate chirality dovetails with trends toward precision pharmaceuticals, chiral electronics and origin-of-life research; a century hence it may be seen as a conceptual bridge between classical synthesis and truly programmable molecular manufacturing. While headlines hail the prize, the deeper story is that selective symmetry-breaking—once a quirk of biology—has become an engineered tool, pushing chemistry from trial-and-error toward deterministic control of matter.